New vaccine made of common dietary supplements could prevent COVID-19
Scientists from Tel Aviv University developed a new vaccine that contains several common dietary supplements to protect against COVID-19 as well as several common winter...
New COVID-19 nasal spray better than current antibody treatments
Scientists from Northwestern University and elsewhere found that a new protein-based antiviral nasal spray is better than current antibody treatments.
The drug is being advanced...
This oral drug could reduce COVID-19 death risk by 55%
Scientists from Veru Inc., an oncology biopharmaceutical company, found a novel COVID-19 drug reduces deaths by 55% in patients at high risk for Acute...
This new device could kill COVID-19 virus in 60 seconds
Scientists from the University of Alberta and TESER found that a new device uses ultraviolet-C light from hundreds of LED light bulbs to kill...
Long COVID affects 1 in 5 people following infection
Vaccination, masks and better indoor air are our best protections.
Many patients recover from COVID within a week or two, but at least one in five...
Is five days of COVID isolation enough?
When the Centers for Disease Control and Prevention (CDC) said in January it was shifting its recommended isolation period for people infected with COVID-19...
Where you live can affect your COVID death risk
Scientists from the University of Chicago used county-level data and found that different demographic groups are vulnerable to COVID-19 in different ways—often depending on...
This drug is effective in COVID-19 patients
Scientists from Spain confirmed that a drug protease inhibitor aprotinin prevented cells to be infected by the COVID-19 virus.
They found that patients receiving an...
Scientists find the cause of loss of smell in COVID-19
Scientists from Johns Hopkins Medicine found that inflammation caused by COVID-19, rather than the virus itself, may lead to loss of smell.
They found that...
Heart inflammation rare in people with severe COVID-19
Scientists from Niguarda Hospital found heart inflammation occurred in about two out of every 1,000 people hospitalized with COVID-19, and was linked to more...